SlideShare ist ein Scribd-Unternehmen logo
1 von 6
PURE (Prospective Urban Rural
Epidemiology)
PURE (Prospective Urban Rural Epidemiology)
S Yusuf (McMaster University, Hamilton, ON)
European Society of Cardiology 2011 Congress


• A survey of 153 996 adults to examine the relationship of societal influences on
  human lifestyle behaviors, CV risk factors, and incidence of chronic
  noncommunicable diseases
•   Time period: 2003–2009
• Population categories:
     Urban and rural communities in countries categorized as high-income
     (Canada, Sweden, and United Arab Emirates), upper-middle-income
     (Argentina, Brazil, Chile, Malaysia, Poland, South Africa, and Turkey), lower-
     middle-income (China, Colombia, and Iran), and low-income (Bangladesh,
     India, Pakistan, and Zimbabwe)
• Analyzed the use of antiplatelets, beta blockers, ACE inhibitors or ARBs,
  statins, and other agents among persons with CHD or stroke


ACE=angiotensin-converting enzyme; ARB=angiotensin receptor blocker; CHD=coronary heart
disease
PURE: Results (by economic status)

CV drug use for secondary prevention among patients with CHD or
stroke, by nation economic status
CV drug category       High-income (%)   Upper-middle          Lower-middle   Low-income   Overall
                                         income (%)            income (%)     (%)

Antiplatelets          62.0              24.6                  21.9           8.8          25.3

Beta blockers          40.0              25.4                  10.2           9.7          17.4

ACE inhibitors or ARBs 49.8              30.0                  11.1           5.2          19.5

BP-lowering agents     73.8              48.4                  37.4           19.2         41.8

Statins                66.5              17.6                  4.3            3.3          14.6

All decreasing trends from higher- to lower-income, p<0.0001
PURE: Results (urban vs rural)

CV drug use for secondary prevention among patients with CHD or
stroke, urban vs rural populations across all surveyed countries
CV drug category        Urban (%)         Rural (%)


Antiplatelets           27.7              21.5

Beta blockers           20.3              13.1

ACE inhibitors or ARBs 22.3               15.4

BP-lowering agents      47.1              33.7

Statins                 17.2              10.6

All differences urban vs rural, p<0.001
PURE: Commentary*

"These are the cheapest, the safest, and the most effective drugs. And yet we have
a collective global failure."
                                                                    - Dr Salim Yusuf


"A real improvement in global cardiovascular health could likely be obtained through
preventive strategies focused on the well-known risk factors, including lifestyle
changes."

                                                                                 - Dr Aldo Pietro Maggioni




*All comments from PURE: CV drugs underused in poor nations, rural populations
(http://www.theheart.org/article/1268617.do)
Become a member of http://www.theheart.org
    Become a fan on Facebook: http://www.facebook.com/theheartorg
          Follow us on Twitter: http://www.twitter.com/theheartorg

theheart.org is the leading online source of independent cardiology news.
We are the top provider of news and opinions for over 100 000 physicians.

Weitere ähnliche Inhalte

Ähnlich wie PURE trial - Summary & Results

Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
MedicineAndHealthUSA
 
A stitch in time - Vash Mungal-Singh
A stitch in time - Vash Mungal-SinghA stitch in time - Vash Mungal-Singh
A stitch in time - Vash Mungal-Singh
NCAS1
 

Ähnlich wie PURE trial - Summary & Results (20)

The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8 The Hypertension Guidelines JNC 8
The Hypertension Guidelines JNC 8
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
 
Million-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptxMillion-Hearts-Initiative.pptx
Million-Hearts-Initiative.pptx
 
ckd
ckdckd
ckd
 
Ckd 2016 100 1
Ckd 2016 100 1Ckd 2016 100 1
Ckd 2016 100 1
 
A stitch in time - Vash Mungal-Singh
A stitch in time - Vash Mungal-SinghA stitch in time - Vash Mungal-Singh
A stitch in time - Vash Mungal-Singh
 
Beta bloqueadores en hta y falla cardíaca.
Beta bloqueadores en hta y falla cardíaca.Beta bloqueadores en hta y falla cardíaca.
Beta bloqueadores en hta y falla cardíaca.
 
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptxHF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
 
Jaume Marrugat de la Iglesia. Debates en Cardiología
Jaume Marrugat de la Iglesia. Debates en CardiologíaJaume Marrugat de la Iglesia. Debates en Cardiología
Jaume Marrugat de la Iglesia. Debates en Cardiología
 
Telehealth for lifestyle interventions - Laurence Girard, FruitStreet - TFSS
Telehealth for lifestyle interventions - Laurence Girard, FruitStreet - TFSSTelehealth for lifestyle interventions - Laurence Girard, FruitStreet - TFSS
Telehealth for lifestyle interventions - Laurence Girard, FruitStreet - TFSS
 
2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & Stroke2015 Report: Medicines in Development for Heart Disease & Stroke
2015 Report: Medicines in Development for Heart Disease & Stroke
 
Managing Type 2 Diabetes
Managing Type 2 DiabetesManaging Type 2 Diabetes
Managing Type 2 Diabetes
 
The cost of doing nothing
The cost of doing nothing The cost of doing nothing
The cost of doing nothing
 
Heart Failure biomarkers
Heart Failure biomarkersHeart Failure biomarkers
Heart Failure biomarkers
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
Approach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptxApproach to Hypertension - Combination therapy.pptx
Approach to Hypertension - Combination therapy.pptx
 
ASCOT-LLA trial - Summary & Results
ASCOT-LLA trial - Summary & ResultsASCOT-LLA trial - Summary & Results
ASCOT-LLA trial - Summary & Results
 
An Introduction to CVD Racial Disparities
An Introduction to CVD Racial DisparitiesAn Introduction to CVD Racial Disparities
An Introduction to CVD Racial Disparities
 
Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014Hypertension conbinsation therapy 2014
Hypertension conbinsation therapy 2014
 
arterial health in hypertension
 arterial health in hypertension arterial health in hypertension
arterial health in hypertension
 

Mehr von theheart.org

Mehr von theheart.org (20)

ESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentationESC 2012 research highlights: A slideshow presentation
ESC 2012 research highlights: A slideshow presentation
 
AHA 2012 Research Highlights
AHA 2012 Research HighlightsAHA 2012 Research Highlights
AHA 2012 Research Highlights
 
AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation AHA 2010 research highlights: A slideshow presentation
AHA 2010 research highlights: A slideshow presentation
 
TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation TCT 2010 research highlights: A slideshow presentation
TCT 2010 research highlights: A slideshow presentation
 
ESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentationESC 2010 Research Highlights : A slideshow presentation
ESC 2010 Research Highlights : A slideshow presentation
 
CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results CHAMPION trial - Summary & Results
CHAMPION trial - Summary & Results
 
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global EndpointONTARGET trial - Summary & Results with Ramipril Global Endpoint
ONTARGET trial - Summary & Results with Ramipril Global Endpoint
 
OASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACCOASIS-6 trial - Summary & Results at ACC
OASIS-6 trial - Summary & Results at ACC
 
IDEAL trial - Summary & Results
IDEAL trial - Summary & ResultsIDEAL trial - Summary & Results
IDEAL trial - Summary & Results
 
ACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & ResultsACCORD BP trial - Summary & Results
ACCORD BP trial - Summary & Results
 
RIVAL trial - Summary & Results
RIVAL trial - Summary & ResultsRIVAL trial - Summary & Results
RIVAL trial - Summary & Results
 
ACT trial - Summary & Results
ACT trial - Summary & ResultsACT trial - Summary & Results
ACT trial - Summary & Results
 
P-OM3 trial - Summary & Results
P-OM3 trial - Summary & ResultsP-OM3 trial - Summary & Results
P-OM3 trial - Summary & Results
 
TRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & ResultsTRITON-TIMI 38 trial - Summary & Results
TRITON-TIMI 38 trial - Summary & Results
 
SHIFT trial - Summary & Results
SHIFT trial - Summary & ResultsSHIFT trial - Summary & Results
SHIFT trial - Summary & Results
 
PROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & ResultsPROTECT-AF trial - Summary & Results
PROTECT-AF trial - Summary & Results
 
PRELUDE trial - Summary & Results
PRELUDE trial - Summary & ResultsPRELUDE trial - Summary & Results
PRELUDE trial - Summary & Results
 
ALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & ResultsALTITUDE trial - Summary & Results
ALTITUDE trial - Summary & Results
 
PRECOMBAT trial - Summary & Results
PRECOMBAT trial - Summary & ResultsPRECOMBAT trial - Summary & Results
PRECOMBAT trial - Summary & Results
 
OSCAR trial - Summary & Results
OSCAR trial - Summary & ResultsOSCAR trial - Summary & Results
OSCAR trial - Summary & Results
 

Kürzlich hochgeladen

Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Dipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
AlinaDevecerski
 

Kürzlich hochgeladen (20)

The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 8250077686 Top Class Call Girl Service Available
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Jabalpur Just Call 8250077686 Top Class Call Girl Service Available
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Haridwar Just Call 8250077686 Top Class Call Girl Service Available
 

PURE trial - Summary & Results

  • 1. PURE (Prospective Urban Rural Epidemiology)
  • 2. PURE (Prospective Urban Rural Epidemiology) S Yusuf (McMaster University, Hamilton, ON) European Society of Cardiology 2011 Congress • A survey of 153 996 adults to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic noncommunicable diseases • Time period: 2003–2009 • Population categories: Urban and rural communities in countries categorized as high-income (Canada, Sweden, and United Arab Emirates), upper-middle-income (Argentina, Brazil, Chile, Malaysia, Poland, South Africa, and Turkey), lower- middle-income (China, Colombia, and Iran), and low-income (Bangladesh, India, Pakistan, and Zimbabwe) • Analyzed the use of antiplatelets, beta blockers, ACE inhibitors or ARBs, statins, and other agents among persons with CHD or stroke ACE=angiotensin-converting enzyme; ARB=angiotensin receptor blocker; CHD=coronary heart disease
  • 3. PURE: Results (by economic status) CV drug use for secondary prevention among patients with CHD or stroke, by nation economic status CV drug category High-income (%) Upper-middle Lower-middle Low-income Overall income (%) income (%) (%) Antiplatelets 62.0 24.6 21.9 8.8 25.3 Beta blockers 40.0 25.4 10.2 9.7 17.4 ACE inhibitors or ARBs 49.8 30.0 11.1 5.2 19.5 BP-lowering agents 73.8 48.4 37.4 19.2 41.8 Statins 66.5 17.6 4.3 3.3 14.6 All decreasing trends from higher- to lower-income, p<0.0001
  • 4. PURE: Results (urban vs rural) CV drug use for secondary prevention among patients with CHD or stroke, urban vs rural populations across all surveyed countries CV drug category Urban (%) Rural (%) Antiplatelets 27.7 21.5 Beta blockers 20.3 13.1 ACE inhibitors or ARBs 22.3 15.4 BP-lowering agents 47.1 33.7 Statins 17.2 10.6 All differences urban vs rural, p<0.001
  • 5. PURE: Commentary* "These are the cheapest, the safest, and the most effective drugs. And yet we have a collective global failure." - Dr Salim Yusuf "A real improvement in global cardiovascular health could likely be obtained through preventive strategies focused on the well-known risk factors, including lifestyle changes." - Dr Aldo Pietro Maggioni *All comments from PURE: CV drugs underused in poor nations, rural populations (http://www.theheart.org/article/1268617.do)
  • 6. Become a member of http://www.theheart.org Become a fan on Facebook: http://www.facebook.com/theheartorg Follow us on Twitter: http://www.twitter.com/theheartorg theheart.org is the leading online source of independent cardiology news. We are the top provider of news and opinions for over 100 000 physicians.